Mortality similar after single- vs double-lung transplant in autoimmune disease with ILD
WASHINGTON — Patients with systemic autoimmune rheumatic disease who develop interstitial lung disease demonstrate similar 1-year mortality risks following either single- or double-lung transplant, according to data.The finding, presented at ACR Convergence 2024, suggests that, for patients with late-stage lung disease from ILD and systemic autoimmune rheumatic diseases (SARDs), single-lung